Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lexeo Therapeutics, Inc. - Common Stock (NQ:LXEO)

3.160 +0.030 (+0.96%)
Streaming Delayed Price Updated: 11:04 AM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 148,416
Open 3.080
Bid (Size) 3.150 (5)
Ask (Size) 3.190 (3)
Prev. Close 3.130
Today's Range 3.011 - 3.329
52wk Range 2.320 - 19.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pharma Frenzy: Volatility Ignites Biotech Sector
Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value. 
Via MarketBeat
Exposures Product Safety
Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw?
The company reported an adjusted Q4 loss of $0.78 per share, beating expectations for a $0.81 loss. 
Via Stocktwits

Performance

YTD
-52.6%
-52.6%
1 Month
+35.0%
+35.0%
3 Month
-52.0%
-52.0%
6 Month
-63.8%
-63.8%
1 Year
-80.1%
-80.1%

More News

Read More
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
LXEO Stock Earnings: Lexeo Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
Via Benzinga
Exposures Fossil Fuels
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
Via Benzinga
Why Top 4% Biotech Stock Lexeo Therapeutics Just Gave Up A Breakout
Via Investor's Business Daily
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
Via Benzinga
Topics Stocks
Exposures US Equities
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
From Lexeo Therapeutics
Via GlobeNewswire
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
From Lexeo Therapeutics
Via GlobeNewswire
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Via Benzinga
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
From Lexeo Therapeutics
Via GlobeNewswire
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
From Lexeo Therapeutics
Via GlobeNewswire
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
From Lexeo Therapeutics
Via GlobeNewswire
RBC Capital Maintains Outperform Rating for Lexeo Therapeutics: Here's What You Need To Know
Via Benzinga
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
From Lexeo Therapeutics
Via GlobeNewswire
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
From Lexeo Therapeutics
Via GlobeNewswire
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities

Frequently Asked Questions

Is Lexeo Therapeutics, Inc. - Common Stock publicly traded?
Yes, Lexeo Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Lexeo Therapeutics, Inc. - Common Stock trade on?
Lexeo Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexeo Therapeutics, Inc. - Common Stock?
The ticker symbol for Lexeo Therapeutics, Inc. - Common Stock is LXEO on the Nasdaq Stock Market
What is the current price of Lexeo Therapeutics, Inc. - Common Stock?
The current price of Lexeo Therapeutics, Inc. - Common Stock is 3.160
When was Lexeo Therapeutics, Inc. - Common Stock last traded?
The last trade of Lexeo Therapeutics, Inc. - Common Stock was at 04/02/25 11:04 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS